Angiotensin-converting enzyme modulates dopamine turnover in the striatum

Journal of Neurochemistry

Volumn 68, Issue 3, 1997, Pages 1304-1311

  Jenkins, Trisha A ^a   Mendelsohn, Frederick A O ^a   Chai, Siew Yeen ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin converting enzyme; Angiotensin converting enzyme inhibitor; Dopamine; Enkephalin; Perindopril; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DRINKING WATER; GLIAL FIBRILLARY ACIDIC PROTEIN; HOMOVANILLIC ACID; MESSENGER RNA; PERINDOPRIL; PREPROTACHYKININ; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CORPUS STRIATUM; DIALYSATE; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG PENETRATION; ENZYME INHIBITION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MICRODIALYSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031027898     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68031304.x     Document Type: Article

References (48)

1. Allen A. M., Paxinos G., McKinley M. J., Chai S. Y., and Mendelsohn F. A. O. (1991) Localization and characterization of angiotensin II receptor binding sites in the human basal ganglia, thalamus, midbrain, pons and cerebellum. J. Comp. Neurol. 312, 291-298.
2. Allen A. M., MacGregor D. P., Chai S. Y., Donnan G. A., Kaczmarczyk S. J., Richardson K., Kalnins R. M., Ireton J., and Mendelsohn F. A. O. (1992) Angiotensin II receptor binding associated with nigro-striatal dopaminergic neurones in human basal ganglia. Ann. Neurol. 32, 339-344.
3. Barnes J. M., Barnes N. M., Costall B., Coughlan J., Kelly M. E., Naylor R. J., Tomkins D. M., and Williams T. J. (1992) Angiotensin converting enzyme inhibition, angiotensin, and cognition. J. Cardiovasc. Pharmacol. 19 (Suppl.), S63-S71.
4. Benuck M., Berg M. J., and Marks N. (1984) Membrane-bound enzymes and their role in processing of the dynorphins and of the proenkephalin octapeptide Met-enkephalin-Arg-Gly-Leu. Neurochem. Res. 9, 733-749.
5. Beto J. A. and Bansal V. K. (1992) Quality of life in treatment of hypertension - a metaanalysis of clinical trials. Am. J. Hypertens. 5, 125-133.
6. 2 receptor binding in the substantia nigra following intrastriatal injection of a retrograde neurotoxin (volkensin). Neurosci. Lett. 134, 180-182.
7. Blaha C. D., Coury A., Fibiger H. C., and Phillips A. G. (1990) Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis. Neuroscience 34, 699-705.
8. Bulpitt C. J. and Fletcher A. E. (1992) Cognitive function and angiotensin-converting enzyme inhibitors in comparison with other antihypertensive drugs. J. Cardiovasc. Pharmacol. 19(Suppl.), S100-S104.
9. Cascieri M. A., Bull H. G., Mumford R. A., Patchett A. A., Thornberry N. A., and Liang T. (1984) Tripeptidyl carboxyterminal hydrolysis of substance P by purified rat lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422. Mol. Pharmacol. 25, 287-293.
10. Chai S. Y., Christie M. J., Beart P. M., and Mendelsohn F. A. O. (1987a) Effects of nigral dopaminergic lesions and striatal excitotoxin lesions on brain converting enzyme. Neurochem. Int. 10, 101-107.
11. Chai S. Y., Mendelsohn F. A. O., and Paxinos G. (1987b) Angiotensin converting enzyme in rat brain visualised by quantitative in vitro autoradiography. Neuroscience 20, 615-627.
12. Chai S. Y., Perich R., Jackson B., Mendelsohn F. A. O., and Johnston C. I. (1992) Acute and chronic effects of angiotensin-converting enzyme inhibitors on tissue angiotensin-converting enzyme. Clin. Exp. Pharmacol. Physiol. 19 (Suppl. 19), 7-12.
13. Croog S. H., Levine S., Testa M. A., Brown B., Bulpitt C. J., Jenkins C. D., Klerman G. L., and Williams G. H. (1986) The effects of antihypertensive therapy on the quality of life. N. Engl. J. Med. 314, 1657-1664.
14. Currie D., Lewis R. V., McDevitt D. G., Nicholson A. N., and Wright N. A. (1990) Central effects of the angiotensin converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood. Br. J. Clin. Pharmacol. 30, 527-536.
15. Dwoskin L. P., Jewell A. L., and Cassis L. A. (1992) DuP 753. a nonpeptide angiotensin II-1 receptor antagonist, alters dopaminergic function in the rat striatum. Naunyn Schmiedebergs Arch. Pharmacol. 345, 153-159.
16. Gerfen C. R. (1995) Dopamine receptor function in the basal ganglia. Clin. Neuropharmacol. 18 (Suppl.), S162-S177.
17. Gillman M. A. and Sandyk R. (1985) Reversal of captopril-induced psychosis with naloxone. Am. J. Psychiatry 142, 270.
18. Gohlke P., Scholkens B., Henning R., Urbach H., and Unger T. (1989) Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and HOE 288. J. Cardiovasc. Pharmacol. 14 (Suppl.), S32-S36.
19. Grima B., Lamouroux A., Blanot F., Faucon Biguet N., and Mallet J. (1985) Complete coding sequence of rat tyrosine hydroxylase mRNA. Proc. Natl. Acad. Sci. USA 82, 617-621.
20. Harding J. W., Stone L. P., and Wright J. W. (1981) The distribution of angiotensin II binding sites in rodent brain. Brain Res. 205, 265-274.
21. Howells R. D., Kilpatrick D. L., Bhatt R., Monaham J. J., Poonian M., and Udenfried S. (1984) Molecular cloning and sequence determination of rat prepro enkephalin cDNA: sensitive probe for studying transcriptional changes in rat tissues. Proc. Natl. Acad. Sci. USA 81, 7651-7655.
22. Hunter W. M. and Greenwood F. C. (1962) Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194, 495-496.
23. Jenkins T. A., Chai S. Y., Howells D. W., and Mendelsohn F. A. O. (1995) Intrastriatal angiotensin II induces turning in 6-hydroxy dopamine lesioned rats. Brain Res. 691, 213-216.
24. Kalivas P. W. and Stewart J. (1991) Dopamine transmission in the initiation and expression of drag-and stress-induced sensitization of motor activity. Brain Res. Rev. 16, 223-244.
25. 7 by angiotensin converting enzyme from monkey brain. Biochem. Pharmacol. 35, 4499-4500.
26. Krause J. E., Chirgwin J. M., Carter M. S., Xu Z. S., and Hershey A. D. (1987) Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl. Acad. Sci. USA 84, 881-885.
27. Lantz I. and Terenius L. (1985) High enkephanyl peptide degradation due to angiotensin-converting enzyme activity in human CSF. FEBS Lett. 193, 31-34.
28. 1-8 in the striatonigral pathway by the dopaminergic system. Brain Res. 398, 390-392.
29. Li S., Sivam S., McGinty J., Jiang H., Douglass J., Calavetta L., and Hong J. (1988) Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J. Pharmacol. Exp. Ther. 246, 403-408.
30. Lind R. W., Swanson L. W., and Ganten D. (1985) Organisation of angiotensin II immunoreactive cells and fibres in the rat CNS. Neuroendocrinology 40, 2-24.
31. 125I-labelled MK351A. Clin Exp. Pharmacol. Physiol. 11, 431-436.
32. 125I-labelled MK351A. J. Hypertens. 2, 41-44.
33. Mendelsohn F. A. O., Jenkins T. A., and Berkovic S. F. (1993) Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res. 613, 221-229.
34. Murai S., Saito H., Masuda Y., and Itoh T. (1988) Rapid determination of norepinephrine, dopamine, serotonin, their precursor amino acids, and related metabolites in discrete brain areas of mice within ten minutes by HPLC with electrochemical detection. J. Neurochem. 50, 473-479.
35. 7 by inhibiting its degradation in mouse brain. Mol. Pharmacol. 28, 521-526.
36. Palenker J., Lentzen H., and Brandt U. (1984) Enkephalin degradation by enkephalinergic-neuroblastoma cells. Involvement of angiotensin converting enzyme. Naunyn Schmiedebergs Arch. Pharmacol. 325, 214-217.
37. Ruggeri M., Ungerstedt U., Agnati L. F., Mutt V., Harfstrand A., and Fuxe K. (1987) Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat. Neurochem. Int. 10, 509-520.
38. Sakaguchi K., Chai S. Y., Jackson B., Johnston C. I., and Mendelsohn F. A. O. (1987) Blockade of angiotensin converting enzyme in circumventricular organs of the brain after oral lisinopril administration demonstrated by quantitative in vitro autoradiography. Clin. Exp. Pharmacol. Physiol. 14, 155-158.
39. Sakaguchi K., Chai S. Y., Jackson B., Johnston C. I., and Mendelsohn F. A. O. (1988) Differential angiotensin-converting enzyme inhibition in brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography. Neuro-endocrinology 48, 223-228.
40. 3H]SCH 23390. Brain Res. 375, 291-301.
41. Schalling M., Daegerlind A., Brene S., Hallman H., Djurfeldt M., Persson H., Terenius L., Goldstein M., Schlesinger D., and Hökfelt T. (1988) Coexistence and gene expression of phenylethanolamine N-methyltransferase, tyrosine hydroxylase, and neuropeptide tyrosine in the rat and bovine adrenal gland: effects of reserpine. Proc. Natl. Acad. Sci. USA 85, 8306-8310.
42. Sexton P. M., McKenzie J. S., Mason R. T., Moseley J. M., Martin T. J., and Mendelsohn F. A. O. (1986) Localization of binding sites for calcitonin gene-related peptide in rat brain by in vitro autoradiography. Neuroscience 19, 1235-1245.
43. Simonnet G. and Vincent J. D. (1982) Characteristics of angiotensin II binding sites in the neostriatum of the rat brain. Neurochem. Int. 4, 149-155.
44. Skidgel R. A., Engelbrecht S., Johnson A. R., and Erdos E. G. (1984) Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peprides 5, 769-776.
45. Skidgel R. A., Defendini R., and Erdos E. G. (1987) Angiotensin I converting enzyme and its role in neuropeptide metabolism, in Neuropeptides and Their Peptidases (Turner A. J., ed), pp. 165-182. Ellis Horwood, New York.
46. 5)-enkephalin analgesia by captopril. Brain Res. 188, 295-299.
47. 5]-enkephalin by dipeptidyl carboxypeptidase. Neuropharmacology 20, 891-894.
48. Zubenko G. S. and Nixon R. A. (1984) Mood-elevating effect of captopril in depressed patients. Am. J. Psychiatry 141, 110-111.